RNF123 Activators
RNF123, a protein that plays a pivotal role in ubiquitin-mediated protein degradation, is modulated by a variety of chemical compounds that influence cellular pathways and protein stability. Compounds like MG-132 [Z-Leu- Leu-Leu-CHO], a proteasome inhibitor, enhance the activity of RNF123 by stabilizing proteins within the ubiquitination pathway, potentially increasing substrate availability for RNF123 and thus amplifying its role in protein ubiquitination and degradation. Similarly, Parthenolide, through its inhibition of NF-κB signaling, can indirectly modulate the ubiquitination process, augmenting RNF123's functionality in protein degradation. Chloroquine and Bafilomycin A1, by altering endosomal and lysosomal pH, impact the degradation pathways of ubiquitinated proteins, thereby indirectly enhancing RNF123's involvement in the ubiquitin-proteasome system. This alteration in the degradation environment is crucial for RNF123's function in protein turnover.
In addition to these, HDAC inhibitors like Trichostatin A and Valproic Acid modify chromatin dynamics and gene expression, potentially upregulating RNF123 or enhancing its role in ubiquitin-mediated protein degradation. These changes in gene expression patterns significantly influence the ubiquitination pathway. Furthermore, Rapamycin, an mTOR inhibitor, creates a cellular environment favorable for RNF123's activity in the ubiquitin-proteasome system by modulating cell growth and autophagy pathways. Lithium Chloride, through its inhibition of GSK-3β, and MEK inhibitors like U0126 and PD 98059, also indirectly enhance RNF123's function in protein degradation by influencing cellular signaling pathways relevant to ubiquitination. Finally, SB 431542, a TGF-β receptor inhibitor, can indirectly bolster RNF123's activity by affecting TGF-β signaling, which is intertwined with protein ubiquitination and degradation pathways. Collectively, these compounds, through their targeted impact on various cellular mechanisms, synergistically enhance the functional activity of RNF123, underscoring its integral role in maintaining protein homeostasis within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Targets NF-κB signaling, a pathway that can indirectly modulate the ubiquitination process in which RNF123 is involved. By inhibiting NF-κB, Parthenolide may enhance the functional activity of RNF123 in ubiquitin-mediated protein degradation. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Alters endosomal and lysosomal pH, impacting the degradation pathways of ubiquitinated proteins. By modifying the endo-lysosomal environment, Chloroquine may indirectly enhance RNF123's role in the ubiquitin-proteasome system. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Inhibits V-ATPase, affecting endosomal acidification and the lysosomal degradation pathway. This inhibition can indirectly boost RNF123's function in ubiquitin-mediated protein degradation by altering the degradation environment of ubiquitinated proteins. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase (HDAC) inhibitor, it changes chromatin dynamics and gene expression, potentially enhancing RNF123's role in ubiquitin-mediated protein degradation by altering the expression of proteins involved in the ubiquitination pathway. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can lead to demethylation and activation of certain genes. This may indirectly enhance RNF123 expression or activity by promoting a more transcriptionally active chromatin state, thereby influencing the ubiquitination pathway. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Functions as an HDAC inhibitor, affecting chromatin structure and gene expression. It may upregulate RNF123 expression or enhance its function in the ubiquitin-proteasome system by altering chromatin accessibility. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, a key regulator of cell growth and autophagy. By affecting these cellular processes, Rapamycin may create an environment that favors the activity of RNF123 in the ubiquitin-proteasome system. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β, a kinase involved in various cellular pathways including protein degradation. Lithium Chloride's inhibition of GSK-3β may enhance the role of RNF123 in the ubiquitin-proteasome system. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
As a MEK inhibitor, it can indirectly influence the ubiquitination process by modulating signaling pathways related to protein degradation, potentially enhancing RNF123's function in this pathway. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits the TGF-β receptor, impacting TGF-β signaling pathways. This inhibition can indirectly enhance RNF123 expression and activity, as TGF-β signaling interacts with pathways regulating protein ubiquitination and degradation where RNF123 is involved. | ||||||